Ackman: Allergan Not Being Raided in Valeant Deal

Ackman: Allergan Not Being Raided in Valeant Deal Play

April 23 (Bloomberg) -- Bill Ackman, CEO at Pershing Square Capital and Michael Pearson, Chairman/CEO at Valeant Pharmaceuticals, discuss their joint bid for Allergan and explain how and why they partnered for the deal on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus